Willingness of gynecologic cancer patients to participate in clinical trials

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 161-165

  Mathews, C ^a   Restivo, A ^b   Raker, C ^c   Weitzen, S ^d   DiSilvestro, P ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

^c Division of Research Women and Infants Hospital   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Cancer; Clinical trials; Gynecologic oncology; Patient willingness

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PATIENT; CAUCASIAN; CLINICAL RESEARCH; EDUCATIONAL STATUS; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; YOUNG ADULT;

EID: 57649103807     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.09.003     Document Type: Article

References (16)

1. Colon-Otero G., Smallridge R., Solberg L., Keith T., Woodward T., Willis F., et al. Disparities in participation in cancer clinical trials in the United States. Cancer 112 (2008) 447-454
2. Tejeda H.A., Green S.B., Trimble E.L., Ford L., High J.L., Ungerleider R.S., et al. Representation of African-Americans, Hispanics, and Whites in National Cancer Institute cancer treatment trials. JNCI 88 (1996) 812-816
3. Comis R.L., Miller J.D., Aldige C.R., Krebs L., and Stoval E. Public attitudes toward participation in cancer clinical trials. JCO 21 (2003) 830-835
4. Ellis P.M., Butow P.N., Martin T., Dunn S.M., and Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. JCO 15 (2001) 3554-3561
5. Markman M., Petersen J., and Montgomery R. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials. Cancer 4 (2006) 849-853
6. Lewis J., Kilgore M.L., Goldman D.P., Trimble E.L., Kaplan R., Montello M.J., et al. Participation of patients 65 years of age or older in cancer clinical trials. JCO 21 (2003) 1383-1389
7. Castel P., Negrier S., and Boissel J.P. Why don't cancer patients enter clinical trials?. Europ. J. Ca. 42 (2006) 1744-1748
8. National Cancer Institute. Clinical trials recruitment and enrollment: attitudes, barriers, and motivating factors. [Online]. 2004 [cited 2008 Feb 27] Available from: URL:http://www.cancer.gov/compendium/clinical-trials-recruitment.pdf.
9. Wright J.R., Whelan T.J., Schiff S., Dubois S., Crooks D., Haines P.T., et al. Why cancer patients enter randomized clinical trails: exploring the factors that influence their decision. JCO 22 (2004) 4312-4318
10. Jenkins V., and Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br. J. Cancer. 82 (2000) 1783-1788
11. National Cancer Institute. Enhancing recruitment to early phase cancer clinical trials: literature review. [Online]. 2004 [cited 2008 Feb 27] Available from URL:http://www.cancer.gov/compendium/enhancing-recruitment-early-phase-ct-lit-review.pdf.
12. Lara P.N., Paterniti D.A., Chiechi C., Turrell C., Morain C., Horan N., et al. Evaluation of factors affecting awareness of and willingness to participate in clinical trials. JCO 23 (2005) 9282-9289
13. Surveillance, Epidemiology, and End Results (SEER) Program: Cancer Statistics. http://seer.cancer.gov/. Accessed July 2008-August 2008.
14. Harter P., duBois A., Schade-Brittinger C., Burges A., Wollschlaeger K., Gropp M., et al. Non-enrollment of ovarian cancer patients in clinical trials: reasons and background. Ann. Oncol. 16 (2005) 1801-1805
15. Wendler D., Kington R., Madans J., Van Wye G., Christ-Schmidt H., Pratt L.A., et al. Are racial and ethnic minorities less willing to participate in health research?. PLoS. Med. 2 (2006) e19
16. Sateren W.B., Trimble E.L., Abrams J., Brawley O., Breen N., Ford L., et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. JCO 20 (2002) 2109-2117